Oncotelic Therapeutics Inc

Oncotelic Therapeutics, a South San Francisco biotech, develops small‑molecule injectable cancer drugs, aiming to fill unmet needs while navigating volatile stock performance.

Oncotelic Therapeutics boosts oncology drug pipeline with AI‑powered partnership and AI‑compliance spotlight, accelerating small‑molecule development and market readiness.

Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering innovative cancer treatment therapies through small molecule injectable drugs, with a focus on transforming cancer care and offering new hope to patients.